Case Studies · Amandeep Singh, Ph.D. ·

RWD market assessment for market entry - Data curation platform

Evaluated the real-world data (RWD) market to assess pricing, key use cases, and unmet needs for a data harmonization AI start-up exploring market entry.

Objective

Who: A start-up with an AI-driven data harmonization platform, with a robust preclinical focused business.

What: Wanted to identify the key use cases, unmet needs, and future opportunities in harmonizing RWD, with a particular focus on data access from multiple sources by biopharma users.

Our Approach

Secondary Research

  • Analyzed competitive landscape and evaluated offerings of the top 7 RWD players focused on clinico-genomic data-mapped disclosure of data sources, focus areas and key value propositions

Primary Research

  • Conducted 22 in-depth interviews with senior-level stakeholders from large pharma, RWD companies and tech platform companies to understand key challenges in data integrity and harmonization, pricing, implementation challenges, data prioritization and purchase criteria.

Quantitative Analysis

  • Projected overall revenue of key players across segments and overall RWD market size

  • Built models for revenue/per datapoint based on diverse data combinations.

Outcomes:

  • Established the key use cases based on biopharma business vertical and data type

  • Captured customer sentiments for unmet needs in data quality, and harmonization. Additionally mapped current processes used by biopharma customers to integrate data, including key challenges.

  • Semi-quantitatively assessed the RWD market size and pricing strategies to prioritize and maximize value delivery

Subscribe to The BioStrat Brief on LinkedIn